Judith Anne Shizuru - Sep 22, 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Herb Cross, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Sep 22, 2025
Transactions value $
$99,630
Form type
4
Date filed
9/24/2025, 04:01 PM
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shizuru Judith Anne Director C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE #102, REDWOOD CITY /s/ Herb Cross, as Attorney-in-Fact 2025-09-24 0001883000

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Purchase $99.6K +41K +35.38% $2.43 157K Sep 22, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Common Stock Warrant (right to buy) Purchase +41K 41K Sep 22, 2025 Voting Common Stock 41K $2.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.